Breaking News Instant updates and real-time market news.

ARIA

Acquired by TKPYY 2/17

$23.68

-0.07 (-0.29%)

, TKPYY

Takeda Pharmaceutical Co. Ltd.

$21.61

-0.11 (-0.51%)

08:21
01/11/17
01/11
08:21
01/11/17
08:21

ARIAD downgraded following deal at SunTrust

As noted earlier, SunTrust downgraded ARIAD (ARIA) to Hold from Buy. Analyst Yatin Suneja downgraded the shares after the company agreed to be acquired by Takeda (TKPYY). The analyst expects the deal to close. Target to $24 from $22.

ARIA

Acquired by TKPYY 2/17

$23.68

-0.07 (-0.29%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$21.61

-0.11 (-0.51%)

  • 11

    Jan

  • 11

    Jan

  • 21

    Feb

  • 29

    Apr

ARIA Acquired by TKPYY 2/17
$23.68

-0.07 (-0.29%)

01/10/17
JEFF
01/10/17
DOWNGRADE
Target $24
JEFF
Hold
ARIAD downgraded to Hold from Buy at Jefferies
Jefferies analyst Eun Yang downgraded ARIAD Pharmaceuticals to Hold on expectations the Takeda acquisition will close by the end of February. The analyst views the deal as a "nice surprise at a significant premium." She raised her price target for the shares to $24 from $11.
01/10/17
LEER
01/10/17
NO CHANGE
LEER
Outperform
ARIAD acquisition supports potential takeout premium for TESARO, says Leerink
Leerink analyst Seamus Fernandez says the acquisition of ARIAD (ARIA) by Takeda (TKPYY) for $24 per share appears to be relatively in-line with other commercial stage acquisitions, and supports a potential acquisition price for TESARO (TSRO) of greater than $170 per share based on consensus forecasts. While TESARO remains well positioned to grow independently, the analyst believes a validated PARP inhibitor like niraparib could offer a durable and strategically important product opportunity for multiple suitors. He reiterates an Outperform rating on TESARO's shares.
01/10/17
LEER
01/10/17
DOWNGRADE
LEER
Market Perform
ARIAD downgraded to Market Perform from Outperform at Leerink
Leerink downgraded ARIA to Market Perform following the acquisition by Takeda for $24 per share.
01/11/17
RHCO
01/11/17
DOWNGRADE
RHCO
Hold
ARIAD downgraded to Hold from Buy at SunTrust
TKPYY Takeda Pharmaceutical Co. Ltd.
$21.61

-0.11 (-0.51%)

07/07/16
UBSW
07/07/16
INITIATION
UBSW
Neutral
Takeda Pharmaceutical initiated with a Neutral at UBS
UBS analyst Atsushi Seki started Takeda with a Neutral rating and Y4,600 price target.
09/14/16
SBSH
09/14/16
NO CHANGE
Target $4
SBSH
Neutral
Citi views Synergy Pharmaceuticals as potential target for Takeda
Citi analyst Liav Abraham calls Synergy Pharmaceuticals (SGYP) the most likely potential target for Takeda Pharmaceutical (TKPYY) among her coverage universe. The Financial Times earlier today reported that Takeda is ready to spend as much as $15B in acquisitions to expand its business in the United States. Abraham has a Neutral rating on Synergy with a $4 price target. The analyst sees Synergy as a potential target given the "extensive resources" needed to commercialize its lead asset, plecanatide, as well as Takdea's presence in the irritable bowel syndrome/chronic idiopathic constipation space. Shares of Synergy are up 6% to $5.18 in early trading.
09/15/16
WELS
09/15/16
NO CHANGE
WELS
Street underestimating potential of PRA Health deal, says Wells Fargo
Wells Fargo believes that the Street is underestimating the potential benefit to PRA Health (PRAH) of its deal with Takeda (TKPYY). The firm expects PRA's bookings over the next year to significantly exceed the industry average, causing 2017 and 2018 consensus estimates for the company to rise. Wells raised its price target on PRA to $65-$67 from $56-$59 and keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

NC

Nacco Industries

$66.30

-0.3 (-0.45%)

06:25
08/21/17
08/21
06:25
08/21/17
06:25
Syndicate
Hamilton Beach Brands files registration statement related to proposed spin-off »

NACCO Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$66.58

-0.02 (-0.03%)

06:19
08/21/17
08/21
06:19
08/21/17
06:19
Hot Stocks
David Tenney says has left Citi after four years »

David Tenney, formerly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$910.67

-0.31 (-0.03%)

, GOOGL

Alphabet Class A

$926.18

-1.48 (-0.16%)

06:18
08/21/17
08/21
06:18
08/21/17
06:18
Hot Stocks
Google expected to release Android O today »

Google is expected to…

GOOG

Alphabet

$910.67

-0.31 (-0.03%)

GOOGL

Alphabet Class A

$926.18

-1.48 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

WFC

Wells Fargo

$51.68

-0.12 (-0.23%)

06:17
08/21/17
08/21
06:17
08/21/17
06:17
Periodicals
Elizabeth Warren criticizes Wells Fargo's board changes, BI says »

After Wells Fargo named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 12

    Oct

  • 15

    Jan

MSFT

Microsoft

$72.49

0.09 (0.12%)

06:16
08/21/17
08/21
06:16
08/21/17
06:16
Periodicals
Microsoft's Xbox One X to launch on November 7, Business Insider reports »

Microsoft's upcoming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

GE

General Electric

$24.55

-0.2 (-0.81%)

06:09
08/21/17
08/21
06:09
08/21/17
06:09
Periodicals
Jeff Immelt becomes front-runner to head Uber, Recode says »

Former General Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 02

    Oct

GS

Goldman Sachs

$222.15

0.73 (0.33%)

, C

Citi

$66.58

-0.02 (-0.03%)

06:08
08/21/17
08/21
06:08
08/21/17
06:08
Periodicals
Goldman Sachs receives approval to trade equities in Saudi Arabia, Reuters says »

Goldman Sachs (GS) has…

GS

Goldman Sachs

$222.15

0.73 (0.33%)

C

Citi

$66.58

-0.02 (-0.03%)

CS

Credit Suisse

$14.88

0.18 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

KOS

Kosmos

$6.91

0.16 (2.37%)

06:05
08/21/17
08/21
06:05
08/21/17
06:05
Hot Stocks
Kosmos announces admission to trading on London Stock Exchange »

Kosmos Energy is pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRV

ContraVir Pharmaceuticals

$0.60

0.0098 (1.66%)

06:03
08/21/17
08/21
06:03
08/21/17
06:03
Hot Stocks
ContraVir Pharmaceuticals issued new U.S. patent for expansion of cyclophilin »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

T

AT&T

$37.37

-0.23 (-0.61%)

, TWX

Time Warner

$101.19

-0.42 (-0.41%)

06:03
08/21/17
08/21
06:03
08/21/17
06:03
Periodicals
AT&T's proposed Time Warner takeover reaches late-stage point, WSJ reports »

The review of…

T

AT&T

$37.37

-0.23 (-0.61%)

TWX

Time Warner

$101.19

-0.42 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

ADP

ADP

$104.41

-0.27 (-0.26%)

06:01
08/21/17
08/21
06:01
08/21/17
06:01
Hot Stocks
ADP board rejects Pershing Square nominees for 2017 annual meeting »

ADP announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

SPX

S&P 500

06:00
08/21/17
08/21
06:00
08/21/17
06:00
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDX

Market Vector Gold Miners

$22.93

-0.1 (-0.43%)

05:59
08/21/17
08/21
05:59
08/21/17
05:59
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$122.30

-0.19 (-0.16%)

05:58
08/21/17
08/21
05:58
08/21/17
05:58
Technical Analysis
SPDR Gold Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUGT

Direxion Gold Miners Bull

$32.21

-0.56 (-1.71%)

05:58
08/21/17
08/21
05:58
08/21/17
05:58
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBR

KBR

$14.92

-0.02 (-0.13%)

05:57
08/21/17
08/21
05:57
08/21/17
05:57
Hot Stocks
KBR awarded PMC contract by OMV Offshore Abu Dhabi GmbH »

KBR announced it has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$18.02

-0.03 (-0.17%)

05:57
08/21/17
08/21
05:57
08/21/17
05:57
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUST

Direxion Daily Gold Miners Bear 3X ETF

$26.95

0.37 (1.39%)

05:57
08/21/17
08/21
05:57
08/21/17
05:57
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$61.01

0.04 (0.07%)

05:57
08/21/17
08/21
05:57
08/21/17
05:57
Technical Analysis
Direxion Daily Junior Gold Miners Index Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXX

iPath S&P 500 VIX Short-Term Futures

$13.30

-0.36 (-2.64%)

05:55
08/21/17
08/21
05:55
08/21/17
05:55
Technical Analysis
iPath S&P 500 VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XIV

VelocityShares Daily Inverse VIX Short-Term ETN

$73.89

2.39 (3.34%)

05:55
08/21/17
08/21
05:55
08/21/17
05:55
Technical Analysis
VelocityShares Daily Inverse VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVIX

VelocityShares Daily 2x VIX Short-Term ETN

$21.25

-1.03 (-4.62%)

05:55
08/21/17
08/21
05:55
08/21/17
05:55
Technical Analysis
VelocityShares Daily 2x VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVXY

ProShares Short VIX Short-Term Futures

$70.66

2.42 (3.55%)

05:55
08/21/17
08/21
05:55
08/21/17
05:55
Technical Analysis
ProShares Short VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$9.97

0.35 (3.64%)

05:54
08/21/17
08/21
05:54
08/21/17
05:54
Technical Analysis
United States Oil Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOP

SPDR Oil Exploration and Production Fund

$29.46

0.36 (1.24%)

05:53
08/21/17
08/21
05:53
08/21/17
05:53
Technical Analysis
SPDR Oil Exploration and Production Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.